galileo life sciences
Successful business transitions
What we do
We are a consulting firm specializing in supporting businesses through strategic inflections, leadership transitions, acquisitions, partnerships, and divestitures.
We serve companies from the biopharmaceutical, medical technology and related sectors.
Our clients are mainly Chief Executives, Boards of Directors and Principal Investors.
OUR expertise
Our senior team has decades of experience and an extensive industry network.
Our team has deep expertise in Strategy, Finance, Organizational alignment, and Transactions.
Some of our services are provided jointly with Galileo Global Securities, a SEC-registered and FINRA-affiliated broker-dealer.
OUR DIFFERENCE
We are rapid and efficient, and we deploy small, high-impact teams that work collaboratively with our clients and leverage our extensive network of experts.
Our unique combination of strategy and investment banking skills drives our strong focus on shareholder value and smooth transition from strategy to execution.
We are happy to share in your success and accept contingent fees and payment in equity.
Leadership
Charles-André Brouwers
Paul Sekhri
Carlo de Notaristefani
Managing Partner, Galileo life sciences
Charles-André Brouwers
Charles-André has thirty-year years of experience consulting to the biopharma and medical device industries. He worked closely with the CEOs, Senior Executives, and Boards of many Pharmaceutical and Medtech companies. Previous to founding Galileo Life Sciences, he was Senior Partner and Managing Director at the Boston Consulting Group and before Head of the Life Sciences Group of Capgemini.
Charles-André is a registered representative affiliated with Galileo Global Securities, LLC is a broker-dealer registered with the SEC, a member of the Financial Industry Regulatory Authority (FINRA)
Founding Advisor, Galileo Life Sciences
Paul Sekhri
Paul has decades of experience leading life sciences companies as CEO, Chairman and board member CEO including at vTv Therapeutics, eGenesis, Lycera, Cerimon and ARIAD Pharmaceuticals. He was Chief Strategy Officer at Teva pharmaceutical and Senior Vice President business development and global head, early commercial development at Novartis. Paul is a founding member of Galileo Life Sciences.
Executive Advisor
Carlo de Notaristefani
Carlo is an international biopharmaceutical operations senior executive with broad technical, operational, and P&L experience. He has deep expertise in designing, operating, and optimizing complex supply chains. He currently serves on the board of several pharma and CMO companies and advises companies and investors.
In 2020, Carlo joined Operation Warp Speed/Federal Covid Response as the lead advisor for Manufacturing and Supply Chain. His previous roles include Executive VP of Operations at Teva Pharmaceuticals Inc. and President Technical Operations and Global Support Functions for Bristol Myers Squibb.